SCHEMBL29873391

SCHEMBL29873391

CCOc1ccccc1OCCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1

nearest known ligand 0.94

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA1A P35348 10/20 0.94
▸ ADRA1D P25100 9/20 0.94
▸ ADRA1B P35368 9/20 0.94
▸ ADRB2 P07550 4/20 0.94
▸ ADRB1 P08588 2/20 0.94
▸ HTR1A P08908 2/20 0.94
▸ ADRA2A P08913 2/20 0.94
▸ DRD2 P14416 2/20 0.94
▸ ADRA2B P18089 2/20 0.94
▸ ADRA2C P18825 2/20 0.94
▸ HTR2A P28223 2/20 0.94
▸ DRD3 P35462 2/20 0.94
▸ HTR2B P41595 2/20 0.94
▸ KCNH2 Q12809 2/20 0.94
▸ HTR7 P34969 1/20 0.94
▸ OPRM1 P35372 1/20 0.94
▸ SIGMAR1 Q99720 2/20 0.49
▸ KDM4E B2RXH2 3/20 0.46
▸ POLB P06746 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tamsulosin SCHEMBL3343160 0.97 ADRA1A (1.00) ADRA1AADRA1DADRA1BADRB2ADRB1
Tamsulosin SCHEMBL29566149 0.97 ADRA1A (1.00) ADRA1AADRA1DADRA1BADRB2ADRB1
Tamsulosin SCHEMBL30361066 0.97 ADRA1A (1.00) ADRA1AADRA1DADRA1BADRB2ADRB1
Tamsulosin SCHEMBL30465862 0.97 ADRA1A (1.00) ADRA1AADRA1DADRA1BADRB2ADRB1
Tamsulosin SCHEMBL34378 0.97 ADRA1A (1.00) ADRA1AADRA1DADRA1BADRB2ADRB1
Tamsulosin SCHEMBL29588704 0.97 ADRA1A (1.00) ADRA1AADRA1DADRA1BADRB2ADRB1
Tamsulosin SCHEMBL53998 0.97 ADRA1A (1.00) ADRA1AADRA1DADRA1BADRB2ADRB1
Tamsulosin SCHEMBL29363851 0.97 ADRA1A (1.00) ADRA1AADRA1DADRA1BADRB2ADRB1
Tamsulosin SCHEMBL29599595 0.97 ADRA1A (1.00) ADRA1AADRA1DADRA1BADRB2ADRB1
Tamsulosin SCHEMBL23428 0.96 ADRA1A (0.98) ADRA1AADRA1DADRA1BADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11884734-B2 Anti-MET antibodies and methods of use thereof CELLDEX THERAPEUTICS, INC. (US) 2024-01-30 — — US disclosed
US-11427632-B2 Antibodies with low immunogenicity and uses thereof CELGENE CORPORATION (US) 2022-08-30 — — US disclosed
Send feedback